|
Volumn 49, Issue 1, 2003, Pages 96-102
|
Thalidomide: new perspectives for its use as antiinflammatory, immunossupressive and antiangiogenic drug;Talidomida: novas perspectivas para utilização como antiinflamatório, imunossupressor e antiangiogênico.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ANTIINFLAMMATORY AGENT;
IMMUNOSUPPRESSIVE AGENT;
THALIDOMIDE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
CHEMISTRY;
ERYTHEMA NODOSUM;
HUMAN;
MULTIPLE MYELOMA;
REVIEW;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
ANGIOGENESIS INHIBITORS;
ANTI-HIV AGENTS;
ANTI-INFLAMMATORY AGENTS;
ERYTHEMA NODOSUM;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
MULTIPLE MYELOMA;
THALIDOMIDE;
MLCS;
MLOWN;
|
EID: 0038150108
PISSN: 01044230
EISSN: None
Source Type: Journal
DOI: 10.1590/s0104-42302003000100041 Document Type: Review |
Times cited : (7)
|
References (62)
|